The/DT
predominant/JJ
E2F/NN
complex/NN
in/IN
human/JJ
primary/JJ
haemopoietic/JJ
cells/NNS
and/CC
in/IN
AML/NN
blasts/NNS
contains/VBZ
E2F-4/NN
,/,
DP-1/NN
and/CC
p130/NN
./.

The/DT
E2F/NN
family/NN
of/IN
transcription/NN
factors/NNS
are/VBP
thought/VBN
to/TO
play/VB
an/DT
important/JJ
role/NN
in/IN
the/DT
control/NN
of/IN
cell/NN
cycle/NN
progression/NN
./.
=====
There/EX
is/VBZ
now/RB
also/RB
increasing/VBG
evidence/NN
that/IN
some/DT
family/NN
members/NNS
may/MD
act/VB
as/IN
oncogenes/NNS
or/CC
tumour/NN
suppressor/NN
genes/NNS
./.
=====
The/DT
characterization/NN
of/IN
these/DT
proteins/NNS
in/IN
human/JJ
primary/JJ
haemopoietic/JJ
cells/NNS
and/CC
acute/JJ
myeloid/JJ
leukaemia/NN
(/(
AML/NN
)/)
blasts/NNS
may/MD
thus/RB
give/VB
an/DT
insight/NN
to/TO
the/DT
molecular/JJ
mechanisms/NNS
governing/VBG
proliferation/NN
and/CC
leukaemogenesis/NN
in/IN
these/DT
cells/NNS
./.
=====
Therefore/RB
we/PRP
analysed/VBD
the/DT
expression/NN
of/IN
E2F-DNA/NN
binding/NN
activity/NN
and/CC
the/DT
constituent/JJ
proteins/NNS
found/VBN
in/IN
the/DT
complexes/NNS
in/IN
human/JJ
primary/JJ
haemopoietic/JJ
cells/NNS
of/IN
various/JJ
lineages/NNS
./.
=====
We/PRP
also/RB
studied/VBD
blasts/NNS
from/IN
18/CD
patients/NNS
with/IN
acute/JJ
myeloid/JJ
leukaemia/NN
(/(
AML/NN
)/)
./.
=====
On/IN
electromobility/NN
shift/NN
assays/NNS
(/(
EMSA/NNS
)/)
a/DT
single/JJ
E2F-DNA/NN
binding/NN
complex/NN
was/VBD
detected/VBN
in/IN
T/NN
cells/NNS
,/,
B/NN
cells/NNS
and/CC
monocytes/NNS
which/WDT
was/VBD
shown/VBN
to/TO
contain/VB
E2F-4/NN
,/,
DP-1/NN
and/CC
p130/NN
,/,
indicating/VBG
that/IN
all/DT
quiescent/JJ
haemopoietic/JJ
cells/NNS
have/VBP
the/DT
same/JJ
complex/NN
./.
=====
Examination/NN
of/IN
18/CD
AML/NN
samples/NNS
by/IN
EMSA/NNS
revealed/VBD
the/DT
presence/NN
of/IN
E2F/NN
binding/NN
and/CC
no/DT
gross/JJ
abnormalities/NNS
were/VBD
detected/VBN
./.
=====
An/DT
E2F-4/p130/NN
complex/NN
was/VBD
detected/VBN
in/IN
representative/JJ
samples/NNS
of/IN
all/DT
FAB/NN
types/NNS
analysed/VBN
./.
=====
Thus/RB
abnormalities/NNS
of/IN
E2F/NN
function/NN
are/VBP
unlikely/JJ
to/TO
play/VB
a/DT
primary/JJ
pathogenic/JJ
role/NN
in/IN
AML/NN
./.